THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 112 filers reported holding THERAVANCE INC in Q1 2015. The put-call ratio across all filers is 57.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $1,075,000 | +46.9% | 102,000 | 0.0% | 0.22% | +39.9% |
Q3 2015 | $732,000 | -19.0% | 102,000 | +104.0% | 0.16% | -10.2% |
Q2 2015 | $904,000 | +15.0% | 50,000 | 0.0% | 0.18% | +15.8% |
Q1 2015 | $786,000 | +11.0% | 50,000 | 0.0% | 0.15% | +10.1% |
Q4 2014 | $708,000 | -17.1% | 50,000 | 0.0% | 0.14% | -20.7% |
Q3 2014 | $854,000 | -42.7% | 50,000 | 0.0% | 0.17% | -41.0% |
Q2 2014 | $1,490,000 | -3.7% | 50,000 | 0.0% | 0.30% | -7.2% |
Q1 2014 | $1,548,000 | – | 50,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |